Literature DB >> 34512790

Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience.

Jyotsna Naresh Bharti1, Poonam Elhence1, Meenakshi Rao1, Aasma Nalwa1, Sudeep Khera1.   

Abstract

OBJECTIVES: The Milan system for reporting salivary gland cytopathology (MSRSGC) classification has been proposed to improve reproducibility in the management of salivary gland lesions. Fine-needle aspiration cytology (FNAC) is a widely accepted, well-tolerated, cost-effective, minimally invasive diagnostic method for pre-operative evaluation of salivary gland lesion that aids management decisions. The present study aims to reclassify the salivary gland FNAC aspirates by applying MSRSGC and calculating the risk of neoplasm and malignancy for each diagnostic category.
MATERIAL AND METHODS: The present study is a retrospective observational study done for 54 months. A total of 168 cases of salivary gland FNA, 54 cases were excised in our institute for histopathology. Retrospective reviews were performed, and the FNAC cases were reclassified according to the Milan system, and the results of FNAC and final histology were correlated, wherever available. Furthermore, the risk of malignancy was calculated for all the diagnostic categories. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy (DA) of FNAC were determined.
RESULTS: In the present study, the age of patients ranged from 3 to 86 years, with a mean age of 39 years. Among all the patients, 61.3% were male, and 38.6% were female. However, only 54 salivary gland FNA samples for which histopathology was available were categorized into six categories. Among them, category IV (neoplastic) had a maximum number of cases of 66.6%. The rate of malignancy was calculated for all diagnostic categories as follows: (1) Non-diagnostic: 0.0%, (2) non-neoplastic 0.0%, (3) atypia of undermined significance 100%, (4a) benign 5.5%, (4b) uncertain malignant potential 33.33%, (5) suspicious for malignancy 00%, and (6) malignancy 80%. The sensitivity, specificity, PPV, NPV, and DA for differentiating between benign and malignant neoplasm were 36.3%, 94.4%, 66.6%, 82.9%, and 80%. Two false-positive and seven false-negative neoplastic cases were noted.
CONCLUSION: FNAC is a reliable, minimally invasive diagnostic method with high DA for diagnosing salivary gland lesions. Most salivary gland lesions can be accurately diagnosed on FNAC with adequate sampling and cytopathologists experience.
© 2021 Cytopathology Foundation Inc, Published by Scientific Scholar.

Entities:  

Keywords:  Cytopathology; Fine-needle aspiration cytology; MEC; Milan; Salivary gland

Year:  2021        PMID: 34512790      PMCID: PMC8422464          DOI: 10.25259/Cytojournal_26_2020

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


  15 in total

1.  Fine-needle aspiration cytology of salivary glands: diagnostic pitfalls--revisited.

Authors:  Arvind Rajwanshi; Kirti Gupta; Nalini Gupta; Rajeev Shukla; Radhika Srinivasan; Raje Nijhawan; Rakesh Vasishta
Journal:  Diagn Cytopathol       Date:  2006-08       Impact factor: 1.582

2.  Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification.

Authors:  Christopher C Griffith; Reetesh K Pai; Frank Schneider; Umamaheswar Duvvuri; Robert L Ferris; Jonas T Johnson; Raja R Seethala
Journal:  Am J Clin Pathol       Date:  2015-06       Impact factor: 2.493

3.  The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): An international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci.

Authors:  Esther Diana Rossi; William C Faquin
Journal:  Cancer Cytopathol       Date:  2018-09-28       Impact factor: 5.284

4.  Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification.

Authors:  Manish Rohilla; Priya Singh; Arvind Rajwanshi; Nalini Gupta; Radhika Srinivasan; Pranab Dey; Rakesh K Vashishta
Journal:  Cancer Cytopathol       Date:  2017-08-07       Impact factor: 5.284

5.  A critical appraisal of the Milan system for reporting salivary gland cytology (MSRSGC) with histological correlation over a 3-year period: Indian scenario.

Authors:  Mukta Pujani; Varsha Chauhan; Charu Agarwal; Sujata Raychaudhuri; Kanika Singh
Journal:  Diagn Cytopathol       Date:  2018-11-12       Impact factor: 1.582

Review 6.  The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an ASC-IAC-sponsored system for reporting salivary gland fine-needle aspiration.

Authors:  Esther Diana Rossi; Zubair Baloch; Marc Pusztaszeri; William C Faquin
Journal:  J Am Soc Cytopathol       Date:  2018-02-13

Review 7.  Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review.

Authors:  Shuanzeng Wei; Lester J Layfield; Virginia A LiVolsi; Kathleen T Montone; Zubair W Baloch
Journal:  Diagn Cytopathol       Date:  2017-03-31       Impact factor: 1.582

8.  The impact of FNAC in the management of salivary gland lesions: Institutional experiences leading to a risk-based classification scheme.

Authors:  Esther Diana Rossi; Lawrence Q Wong; Tommaso Bizzarro; Gianluigi Petrone; Antonio Mule; Guido Fadda; Zubair M Baloch
Journal:  Cancer Cytopathol       Date:  2016-03-09       Impact factor: 5.284

9.  The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens.

Authors:  Sharon J Song; Khurram Shafique; Lawrence Q Wong; Virginia A LiVolsi; Kathleen T Montone; Zubair Baloch
Journal:  Cytopathology       Date:  2018-11-12       Impact factor: 2.073

10.  Effectuation to Cognize malignancy risk and accuracy of fine needle aspiration cytology in salivary gland using "Milan System for Reporting Salivary Gland Cytopathology": A 2 years retrospective study in academic institution.

Authors:  Veer Karuna; Priya Gupta; Monika Rathi; Kriti Grover; Jitendra Singh Nigam; Nidhi Verma
Journal:  Indian J Pathol Microbiol       Date:  2019 Jan-Mar       Impact factor: 0.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.